PMID: 6990663Jan 1, 1980Paper

Clinical antiarrhythmic efficacy of mexiletine: a review

Acta cardiologica. Supplementum
H E Kulbertus

Abstract

This paper consists of a review of some of the most important papers which have recently been devoted to mexiletine. The electrophysiological effects of the drug in normal subjects and in patients with abnormal impulse formation or conduction are described. The results of open studies related to the clinical effects of mexiletine administered intravenously or orally are briefly reported. The efficacy of the drug on ventricular rhythm disorders is then discussed on the basis of data provided by several controlled double-blind studies. The possible role of mexiletine as a protection against sudden death following myocardial infarction is envisaged. The side-effects which were described by the different investigators are listed.

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.